InMed Pharmaceuticals annual current ratio
2020
2021
2022
2023
2024
2025
InMed Pharmaceuticals Current Ratio Growth & History (INM)
InMed Pharmaceuticals's current ratio was 6.99 for fiscal 2025.
View full InMed Pharmaceuticals company overviewInMed Pharmaceuticals annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | 6.99 | 2.59 | +58.70% |
| 2024 | 2024-06-30 | 4.41 | −1.26 | −22.20% |
| 2023 | 2023-06-30 | 5.66 | 2.77 | +95.90% |
| 2022 | 2022-06-30 | 2.89 | −0.89 | −23.55% |
| 2021 | 2021-06-30 | 3.78 | 0.02 | +0.43% |
| 2020 | 2020-06-30 | 3.77 | — | — |
InMed Pharmaceuticals quarterly current ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-03-31 | 3.11 | −0.37 | −10.63% |
| Q2 2026 | 2025-12-31 | 5.94 | 2.88 | +94.42% |
| Q1 2026 | 2025-09-30 | 6.95 | 1.88 | +36.99% |
| Q4 2025 | 2025-06-30 | 6.99 | 2.59 | +58.70% |
| Q3 2025 | 2025-03-31 | 3.49 | — | — |
| Q2 2025 | 2024-12-31 | 3.05 | −3.97 | −56.54% |
| Q1 2025 | 2024-09-30 | 5.07 | −1.12 | −18.15% |
| Q4 2024 | 2024-06-30 | 4.41 | −1.26 | −22.20% |
| Q2 2024 | 2023-12-31 | 7.03 | 1.19 | +20.36% |
| Q1 2024 | 2023-09-30 | 6.19 | 2.68 | +76.11% |
| Q4 2023 | 2023-06-30 | 5.66 | 2.77 | +95.90% |
| Q3 2023 | 2023-03-31 | 5.22 | 3.09 | +144.90% |
| Q2 2023 | 2022-12-31 | 5.84 | 3.13 | +115.61% |
| Q1 2023 | 2022-09-30 | 3.52 | −4.77 | −57.58% |
| Q4 2022 | 2022-06-30 | 2.89 | −0.89 | −23.55% |
| Q3 2022 | 2022-03-31 | 2.13 | −4.23 | −66.48% |
| Q2 2022 | 2021-12-31 | 2.71 | −2.05 | −43.10% |
| Q1 2022 | 2021-09-30 | 8.29 | 5.56 | +203.67% |
| Q4 2021 | 2021-06-30 | 3.78 | 0.02 | +0.43% |
| Q3 2021 | 2021-03-31 | 6.36 | — | — |
| Q2 2021 | 2020-12-31 | 4.76 | — | — |
| Q1 2021 | 2020-09-30 | 2.73 | — | — |
| Q4 2020 | 2020-06-30 | 3.77 | — | — |
InMed Pharmaceuticals current ratio trends
Over the last five fiscal years, InMed Pharmaceuticals's current ratio increased from 3.77 to 6.99, a change of 3.23. The latest reported quarter, Q3 2026, shows 3.11.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review InMed Pharmaceuticals source filings ↗